Banco Macro S.A. (BMA) 78.26 $BMA HSBC's Revenue Woes

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Banco Macro S.A. (BMA) 78.26 $BMA

HSBC's Revenue Woes Linger, Cost Containment on Track
Zacks Equity Research - Zacks Investment Research - Mon Sep 05, 10:38AM CDT
On Sep 5, 2016, we issued an updated research report on HSBC Holdings (HSBC). We believe the company's consistent focus on expense management will enhance its financial stability in the near future.
BMA: 78.26 (-0.20), WBK: 22.27 (-0.02), HSBC: 38.65 (+0.77), GGAL: 30.55 (+0.17)

Deutsche Bank (DB) CEO Dismisses Commerzbank Merger Talks
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 9:26AM CDT
John Cryan, chief executive officer of Deutsche Bank AG (DB) brushed away rumors of a potential merger between Deutsche Bank and Commerzbank AG, the second largest bank in Germany
BMA: 78.26 (-0.20), KB: 35.32 (-0.01), DB: 14.90 (+0.21), BNS: 54.33 (+0.71)

Banco Macro Announces Results for the Second Quarter of 2016
PR Newswire - Tue Aug 09, 4:45PM CDT
Banco Macro S.A. (NYSE: BMA; BCBA: BMA) ("Banco Macro" or "BMA" or the "Bank" announced today its results for the second quarter ended June 30, 2016 ("2Q16". All figures are in Argentine pesos (Ps.) and have been prepared in accordance with Argentine GAAP.
BMA: 78.26 (-0.20)

Banco Macro (BMA) in Focus: Stock Moves 5.9% Higher
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 7:45AM CDT
Banco Macro S.A. (BMA) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
BMA: 78.26 (-0.20), SHG: 37.08 (+0.13)

Banco Macro (BMA) Looks Good: Stock Adds 5.2% in Session
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 7:00AM CDT
Banco Macro S.A (BMA) was a big mover last session, as the company's shares rose over 5% on the day.
BMA: 78.26 (-0.20), BMO: 67.06 (+0.54)

Deutsche Bank (DB) Being Probed on 2011 Italian Bond Sale
Zacks Equity Research - Zacks Investment Research - Tue May 10, 9:02AM CDT
Deutsche Bank AG (DB) is under investigation by Italian authorities related to the bank's sale of 7 billion euro ($8 billion) of Italian government bonds in 2011.
BMA: 78.26 (-0.20), DB: 14.90 (+0.21), GGAL: 30.55 (+0.17), SHG: 37.08 (+0.13)

New Strong Buy Stocks for May 10th
Zacks Equity Research - Zacks Investment Research - Tue May 10, 7:12AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
BMA: 78.26 (-0.20), CBM: 43.27 (+0.10), AZPN: 45.92 (+0.30), BBY: 38.75 (+0.21), BEL: 11.33 (unch)

Deutsche Bank Warned by FCA Over 'Serious' Control Issues
Zacks Equity Research - Zacks Investment Research - Tue May 03, 3:58PM CDT
Deutsche Bank AG (DB) has "serious" failings in anti money laundering controls, per findings by the UK regulator Financial Conduct Authority (FCA).
BMA: 78.26 (-0.20), DB: 14.90 (+0.21), GGAL: 30.55 (+0.17), SHG: 37.08 (+0.13)

HSBC Q1 Earnings: What's in the Cards for the Stock?
Zacks Equity Research - Zacks Investment Research - Mon May 02, 4:15PM CDT
What to expect from HSBC results this earnings season? Will the company again succumb to the revenue pressure or will its restructuring and cost-control efforts support the results?
BMA: 78.26 (-0.20), WBK: 22.27 (-0.02), HSBC: 38.65 (+0.77), GGAL: 30.55 (+0.17)

Banco Macro S.A. Informs the Market of the Filing of its Annual Report on Form 20-F For the Fiscal Year Ended December 31, 2015
PR Newswire - Thu Apr 28, 3:24PM CDT
Banco Macro S.A. (NYSE: BMA; Buenos Aires Stock Exchange: BMA) ("Banco Macro" announces today the filing of its annual report on Form 20-F and the corresponding audited financial statements for the fiscal year ended December 31, 2015 (the "2015 Annual Report" with the Securities and Exchange Commission (the "SEC". The 2015 Annual Report can be accessed by visiting either the SEC's website at www.sec.gov in the Section "Search for Company Filings" under CIK code No. 0001347426 or Banco Macro's Investor Relations website at www.ri-macro.com.ar under the Financial Information /Sec Filing link. In addition, shareholders may receive a hard copy of Banco Macro's complete audited financial statements as of and for the year ended December 31, 2015 free of charge within a reasonable period of time by making a request through Banco Macro's Investor Relations website (www.ri-macro.com.ar), writing to investorelations@macro.com.ar or contacting Banco Marco's Investor Relations Department at (5411) 5222 6682.
BMA: 78.26 (-0.20)

Banco Macro Announces Results for the First Quarter of 2016
PR Newswire - Thu Apr 21, 4:38PM CDT
Banco Macro S.A. (NYSE: BMA; BCBA: BMA) ("Banco Macro" or "BMA" or the "Bank" announced today its results for the first quarter ended March 31, 2016 ("1Q16". All figures are in Argentine pesos (Ps.) and have been prepared in accordance with Argentine GAAP.
BMA: 78.26 (-0.20)

New Strong Buy Stocks for April 19th
Zacks Equity Research - Zacks Investment Research - Tue Apr 19, 8:33AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
BMA: 78.26 (-0.20), BV: 4.05 (unch), ANCX: 22.40 (+0.05), MTGE: 17.34 (+0.33), ATRC: 15.89 (+0.39)

BUYINS.NET: NSH, NUVA, BMA, MMLP, SBS, CVI Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Feb 10, 6:04AM CST
February 10, 2016 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Nustar GP Holdings LLC (NYSE:NSH), NuVasive Inc (NASDAQ:NUVA), Banco Macro SA (NYSE:BMA), Martin Midstream Partners LP (NASDAQ:MMLP), Companhia de Saneamento Basico do Estado de Sao Paulo - SABE (NYSE:SBS), CVR Energy Inc (NYSE:CVI) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
MMLP: 20.19 (+0.41), BMA: 78.26 (-0.20), SBS: 9.49 (+0.57), CVI: 14.00 (+0.03), NSH: 24.71 (+0.28), NUVA: 66.74 (+0.68)

Moody's Cuts Credit Suisse's Ratings Post Plan Review
Zacks Equity Research - Zacks Investment Research - Tue Jan 12, 2:05PM CST
Moody's recently downgraded the long-term ratings of Credit Suisse Group AG (CS) and affiliates. Notably, the senior unsecured debt rating was cut to A2 from A1 and long-term deposit rating was lowered to A1 from Aa3
BMA: 78.26 (-0.20), CS: 13.27 (+0.13), GGAL: 30.55 (+0.17), MCO: 109.43 (+0.88)

UBS AG's Long-term Ratings Lifted by a Notch by Moody's
Zacks Equity Research - Zacks Investment Research - Tue Jan 12, 10:50AM CST
UBS AG - a wholly owned subsidiary of UBS Group AG (UBS) - has received one notch upgrade in its long-term ratings by the Moody's Investors Service
BMA: 78.26 (-0.20), GGAL: 30.55 (+0.17), UBS: 14.71 (+0.25), MCO: 109.43 (+0.88)

Bear of the Day: Banco de Chile (BCH)
David Bartosiak - Zacks Investment Research - Tue Jan 12, 8:01AM CST
Bear of the Day: Banco de Chile (BCH)
BMA: 78.26 (-0.20), BCH: 67.18 (+1.17), GGAL: 30.55 (+0.17)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

China Southern Airlines Marks 70th Anniversary in NYC

Updated Category News Views 4

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 4

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Endurance Energy's Modular Tech Revs Up Southeast Asia

Updated Category News Views 4

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 3

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
AST SpaceMobile Faces Class Action Over Misstatements

Updated Category News Views 4

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Continue Reading
Cut Winter Heating Costs with Townsend's Rebate Help

Updated Category News Views 9

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 3

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 4

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Timur Turlov Leads FIDE with Chess and Digital Focus

Updated Category News Views 5

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 4

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading

Top 5 Most Recently Viewed Articles

Toll Brothers' Q3 Results Show Steady Growth Amid Challenges

Updated Category News Views 160

Overview of Toll Brothers' Q3 Financial Performance On August 19, 2025, Toll Brothers, Inc. (NYSE: TOL), a prominent builder of luxury homes, reported robust financial results for its fiscal year 2025 third quarter, reflecting resilience in the luxury housing market. The results, concluding on July 31, 2025, demonstrate the company's adaptability in navigating current...

Continue Reading
SolarBank Revises Financial Statements for Transparency

Updated Category News Views 245

SolarBank Corporation Updates Financial Disclosures SolarBank Corporation (NASDAQ: SUUN) has recently announced an important update regarding its financial disclosures. The company has refiled its Audited Consolidated Annual Financial Statements for the fiscal year ending June 30, 2024. This refiled documentation was originally submitted on September 30, 2024, and...

Continue Reading
Coldwell Banker Warburg's Exciting Expansion to Brooklyn

Updated Category News Views 195

Coldwell Banker Warburg Expands to Brooklyn New DUMBO-based office marks the brokerage's first brick-and-mortar location in the fast-growing borough Coldwell Banker Warburg (CBW) is thrilled to announce a significant milestone in its expansion journey with the opening of its first office in Brooklyn. The new location, nestled in the vibrant DUMBO neighborhood, showcases...

Continue Reading
How REALTORS® Leverage AI and Tech to Transform Services

Updated Category News Views 187

Understanding the Embrace of AI and Technology by REALTORS® In recent times, the real estate industry has witnessed a remarkable transformation driven by the integration of technology, especially artificial intelligence. REALTORS® have been quick to adapt to these advancements, utilizing digital tools to enhance the services they provide to their clients. The insights...

Continue Reading
Anticipating Regal Rexnord's Earnings: What Investors Should Know

Updated Category News Views 129

Regal Rexnord's Upcoming Earnings Report Regal Rexnord (NYSE: RRX) is set to share its quarterly earnings report soon, igniting significant interest among investors. The anticipation surrounding this report stems from a combination of previous performance and market expectations that suggest growth and optimism. Expectations on Earnings Per Share Analysts have projected...

Continue Reading